OmTerra Holistic Psychedelic Therapy

With deep personal understanding of the benefits and shortcomings of the currently widespread model of psychedelic therapy, OmTerra was founded to expand the potential of psychedelic medicines. 

Steve Elfrink, OmTerra Founder and Psychedelic Somatic Interactional Therapist, was also the Co-Founder of the Psychedelic Somatic Institute (PSI), a psychedelic somatic therapist training organization and OmTerra, a PSIP/IFS focused therapy organization. He was a participant in the 2015, Phase 1 FDA Pharmacokinetic Study of Psilocybin at UW-Madison that also studied the effects of high-dose psilocybin for adverse reactions. Steve has been a pioneer in bringing more awareness to the world of the powerful transformative effects of psychedelics and the more harrowing and less discussed challenges that come with psychedelic therapy.​​ Steve is also someone who has his own history of early childhood trauma and working through it utilizing psychedelic medicines.